REFLECT: Recovery Following Intensive Care Treatment

Slides:



Advertisements
Similar presentations
Navigating the PhD – The Research Degrees Office.
Advertisements

An Introduction to the Ethics Review Procedure Lindsay Unwin: Research & Innovation Services, UREC Secretary.
Involving acute hospital inpatients in the evaluation of an occupational therapy service Cathy Robertson Senior occupational therapist Wirral Hospital.
Facility Level Reviews Photo from:
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.
Developing information for participants in your research – getting started This presentation contains some exercises to help you get started. You can do.
Consent for Research Study RESCUE: Randomized Evaluation of Patients with Stable Angina Comparing Utilization of Diagnostic Examinations ACRIN
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Negotiating access, ethics and the problems of ‘inside’ research.
Presentation 1: Developing information for participants in your research – getting started This presentation contains some exercises to help you get started.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
TRAINING COURSE. Course Objectives 1.Know how to handle a suspected case 2.Know how to care for a recognized trafficked person referred to you Session.
The Mental Health Act & Mental Capacity act Dr Faye Tarrant ST5 Substance Misuse.
Key Knowledge Confidentiality Year 4 Medical Ethics and Law Thread Course The Ethox Centre, University of Oxford.
PATIENT & FAMILY RIGHTS AT DOHMS. Fully understand and practice all your rights. You will receive a written copy of these rights from the Reception, Registration.
ETHICAL ISSUES IN HEALTH AND NURSING PRACTICE CODE OF ETHICS, STANDARDS OF CONDUCT, PERFORMANCE AND ETHICS FOR NURSES AND MIDWIVES.
A Pilot Study of Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging
CLINICAL TRIALS.
Applying for ethical approval
Substance Addiction(Compulsory Assessment and Treatment) Act 2017 Processes
REFLECT: Recovery Following Intensive Care Treatment
Disclosure UK Talking about Transparency.
(<<INSERT LOCAL TRUST LOGO>>)
CONDUCTING THE TRIAL AT
MAINTAINING THE INVESTIGATOR’S SITE FILE
Taking informed consent and withdrawal
And the finer details of patient privacy
What do teachers want from a mental health resource?
Enrolling in Clinical Trials
Research Study Patsy D. Lewis
HOW TO CONSENT A PATIENT?
Facility Level Reviews
Dining with Diabetes IRB Training 2017.
The Children’s Heart Study
The National Data Guardian review & Government response
Research Ethics: a short guide for PhD students 2017/18
Bozeman Health Clinical Research
Disclosure UK Talking about Transparency.
Interview Study Patient Information Leaflet
Geographical Skills Interview Techniques.
Patient information: Research study taking place today
Data Protection and GDPR – An introduction for Baptist Churches
Information for Patients Please return to reception
Recording Clinical Data
HOW TO CONSENT A PATIENT?
Participants’ Rights Participants of clinical trials have rights, and they are protected under law when participating in clinical trials. The informed.
D3 Confidentiality.
“Your Rights as a Hospital Patient” for Seniors
MAINTAINING THE INVESTIGATOR’S STUDY FILE
Informed Consent (SBER)
Wootton Medical Centre High Street, Wootton Northampton NN4 6LW
Recording Clinical Data
Recording Clinical Data
Cindy Murray NP Princess Margaret Cancer Centre
NHS Blackburn with Darwen Clinical Commissioning Group
Right person, right time, right place…
Academy Medical Centre
Consent, throughout the Early Help Journey
Training for Local Authorities
Patient information sheet & Principles of Good Clinical Practice
Human Subjects Research
Handling information 14 Standard.
Advocacy Standards Events
TRACE INITIATIVE: Confidentiality, Data Security, and Procedures for Protocol Violation or Adverse Event.
Informed Consent Before taking part in this study it is important that you understand: This study aims to evaluate the benefits of lessons on sexually.
The National Data Guardian review & Government response
National Hospice and Palliative Care Organization’s Palliative Care Resource Series Creating Support for Your Community-Based Palliative Care Program.
GDPR Information and Consent
Presentation transcript:

REFLECT: Recovery Following Intensive Care Treatment Where can I find the results of the study? The results of this study will be used to inform a plan for looking after patients who have been discharged from intensive care. The findings of the interviews with staff, patients and relatives will also be published in a medical journal to make sure our findings can be used by others. No identifiable information will be published, although some anonymised quotes from interviews may be used. The results may also be included in a PhD thesis. Data sharing We may share anonymised data from the interview with other researchers doing relevant research. It will not be possible for you to be identified by this data. What happens if I have any questions, concerns or complaints about the study? If you have any questions about the study, please ask the person presenting this form to you, or contact Sarah Vollam (01865) 231440. The University of Oxford, as Sponsor, has appropriate insurance in place in the unlikely event that you suffer any harm as a direct consequence of your participation in this study. NHS indemnity operates in respect of the clinical treatment which is provided. If you wish to complain about any aspect of the way in which you have been approached or treated during the course of this study, you should contact Sarah Vollam (01865 231449 or sarah.vollam@ndcn.ox.ac.uk). or you may contact the University of Oxford Clinical Trials and Research Governance (CTRG) office on 01865 572224, or the head of CTRG, email ctrg@admin.ox.ac.uk. Contact details: Kadoorie Centre The John Radcliffe Headley Way Headington Oxford OX3 9DU Email: sarah.vollam@ndcn.ox.ac.uk Tel: 01865 231440 NUFFIELD Department of CLINICAL NEUROSCIENCES (Nuffield division of anaesthetics) University of oxford REFLECT: Recovery Following Intensive Care Treatment Chief Investigator: Dr Peter Watkinson Sub-study B PARTICIPANT INFORMATION SHEET: INTERVIEWS IRAS reference: 187602 Version 2 23/05/2017

What is the purpose of the study? Most patients discharged from an intensive care unit (ICU) are expected to go home. However, despite our best efforts, about 1 in 12 die unexpectedly on general wards before leaving hospital. This high death rate occurs despite hospitals using systems to closely monitor and detect changes in patients’ condition. Also, in many hospitals, patients receive visits from ICU teams. We would like this high death rate to be lower so we intend designing a plan which reduces it. Before the plan can be made, we need to know more about what happens to these patients. To do this, we will speak to staff and patients who have experience of discharge from ICU. We would also like to talk to relatives of patients who were discharged from ICU but did not survive their hospital stay. This will provide a direct view of the patient group this project aims to help. We will combine this information with work from several other sources and work with experts skilled at making plans work. This will allow us to make the best possible plan. The plan that we design as a result of this project will then be tested in a large trial.  Why have I been approached? We are conducting research on what happens to patients who are discharged to wards following intensive care. The aim of this work is to improve the care of these patients and to improve their outcome. To do this, we need to look at what goes well and what could be done better during this period of care. You have been approached because you were discharged from intensive care to a ward. We are really interested in hearing the views of patients who have experienced this care. Do I have to take part? We understand you may not wish to discuss this area of your care. It is up to you to decide whether or not to take part and we completely understand if you do not wish to. If you do decide to take part you will be given this information sheet to keep and be asked to sign a consent form.   What will happen to me if I take part? Those who agree to take part will be invited to attend an interview , with the intention of gathering information on what went well and what could have been improved during this period of care. This would be scheduled at a time convenient to you, probably on the same day as your ICU follow-up appointment, to save you making a special journey. Reasonable travel expenses for attending this interview will be reimbursed. Alternatively, this interview could take place over the phone. If you choose this option, we will talk through the consent form over the phone before you sign it and post back to us. The interview would be conducted by the research nurse, and would be recorded, with your consent. The recording would be written up to allow us to look carefully at what you say. Are there any risks? There are no known risks to this study. However, discussing such a sensitive topic may be distressing to you. The ICU follow-up team will be available initially to answer any questions or concerns you may have about your care. We will also be able to signpost you to other support if required. All information gathered within the interviews will be anonymised at the point of collection, so no individuals will be identifiable.  What are the possible benefits of taking part? There would be no benefits to you from taking part in this study. Sharing your experiences may help to raise awareness of common issues. It is hoped in the longer term that this study will contribute to improved standards of care in the future, and better working practices, based on the information we collect.  What will happen if I don't want to carry on with the study? You are free to withdraw from the study at any time. A decision to withdraw, or a decision not to take part, would not affect you or your care in any way. If you wish to withdraw from the study, we will offer to destroy all information gathered from you. This is possible up until the point where we anonymise data, when it will no longer be possible to identify your individual interview information. Who has approved the study? All research in the NHS is looked at by an independent group of people, called a Research Ethics Committee, to protect your interests. This study has been reviewed and given favourable opinion by _______________Research Ethics Committee Who is organising the research? The Critical Care Research Group, based at the Kadoorie Centre, is organising this research. The study is funded by an NIHR Research for Patient Benefit grant. Would my taking part in this study be kept confidential? All information collected during the course of this study will be kept strictly confidential. All paper documentation will be stored in a secure research facility, behind two locked doors in a locked filing cabinet. Electronic records will be stored within the university system on a secure database with restricted access from the secure research facility and password-protected. Audio recordings of interviews may be sent to an external transcriber, with whom we will have a confidentiality agreement. All data collected will be “anonymised”- that is, will have all names removed and individuals will not be recognisable from it. Anonymised data may be made available to other groups related to the development of this research programme. It is important to note that this interview about your experiences is entirely separate from the NHS complaints procedures.